Literature DB >> 22033256

80-year-old man with massive leg swelling.

Benjamin Kloesel1, Roger F J Shepherd.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22033256      PMCID： PMC3203002          DOI： 10.4065/mcp.2011.0331

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN： 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  15 in total

1.  Intravenous thrombolytic therapy in patients with phlegmasia caerulea dolens.

Authors:  Bernard Tardy; Nathalie Moulin; Patrick Mismetti; Hervé Decousus; Silvy Laporte
Journal:  Haematologica       Date:  2006-02       Impact factor: 9.941

2.  Does the location of thrombosis determine the risk of disease recurrence in patients with proximal deep vein thrombosis?

Authors:  J D Douketis; M A Crowther; G A Foster; J S Ginsberg
Journal:  Am J Med       Date:  2001-05       Impact factor: 4.965

3.  Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism.

Authors:  Agnes Y Y Lee; Frederick R Rickles; Jim A Julian; Michael Gent; Ross I Baker; Chris Bowden; Ajay K Kakkar; Martin Prins; Mark N Levine
Journal:  J Clin Oncol       Date:  2005-02-07       Impact factor: 44.544

Review 4.  May-Thurner syndrome: case report and review of the literature involving modern endovascular therapy.

Authors:  Neil Moudgill; Eric Hager; Carin Gonsalves; Robert Larson; Joseph Lombardi; Paul DiMuzio
Journal:  Vascular       Date:  2009 Nov-Dec       Impact factor: 1.285

5.  Dabigatran versus warfarin in the treatment of acute venous thromboembolism.

Authors:  Sam Schulman; Clive Kearon; Ajay K Kakkar; Patrick Mismetti; Sebastian Schellong; Henry Eriksson; David Baanstra; Janet Schnee; Samuel Z Goldhaber
Journal:  N Engl J Med       Date:  2009-12-10       Impact factor: 91.245

6.  Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer.

Authors:  Agnes Y Y Lee; Mark N Levine; Ross I Baker; Chris Bowden; Ajay K Kakkar; Martin Prins; Frederick R Rickles; Jim A Julian; Susan Haley; Michael J Kovacs; Michael Gent
Journal:  N Engl J Med       Date:  2003-07-10       Impact factor: 91.245

7.  Dabigatran versus warfarin in patients with atrial fibrillation.

Authors:  Stuart J Connolly; Michael D Ezekowitz; Salim Yusuf; John Eikelboom; Jonas Oldgren; Amit Parekh; Janice Pogue; Paul A Reilly; Ellison Themeles; Jeanne Varrone; Susan Wang; Marco Alings; Denis Xavier; Jun Zhu; Rafael Diaz; Basil S Lewis; Harald Darius; Hans-Christoph Diener; Campbell D Joyner; Lars Wallentin
Journal:  N Engl J Med       Date:  2009-08-30       Impact factor: 91.245

8.  Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  Clive Kearon; Susan R Kahn; Giancarlo Agnelli; Samuel Goldhaber; Gary E Raskob; Anthony J Comerota
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

9.  Successful catheter-directed venous thrombolysis in phlegmasia cerulea dolens.

Authors:  Celestine S Tung; Pamela T Soliman; Michael J Wallace; Judith K Wolf; Diane C Bodurka
Journal:  Gynecol Oncol       Date:  2007-08-01       Impact factor: 5.482

Review 10.  Low-molecular-weight heparins are superior to vitamin K antagonists for the long term treatment of venous thromboembolism in patients with cancer: a cochrane systematic review.

Authors:  Elie A Akl; Maddalena Barba; Sandeep Rohilla; Irene Terrenato; Francesca Sperati; Paola Muti; Holger J Schünemann
Journal:  J Exp Clin Cancer Res       Date:  2008-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.